2018
DOI: 10.1016/j.toxrep.2017.12.008
|View full text |Cite
|
Sign up to set email alerts
|

Effects of intragastrically-administered Tepary bean lectins on digestive and immune organs: Preclinical evaluation

Abstract: Graphical abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
12
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 40 publications
(56 reference statements)
1
12
0
1
Order By: Relevance
“…Similar effects were observed with other Tepary bean lectin fractions on different colon cancer cell lines [19,20]. In vivo studies have reported that TBLF (50 mg/kg by intragastric administration for six weeks every third day) exhibits low toxicity, good tolerability and activates the immune system [21,22]. Between the observed adverse effects are loss of body weight, small intestinal villus and colonic crypt atrophy and exocrine pancreas hypertrophy, without systemic adverse effects.…”
Section: Introductionsupporting
confidence: 71%
“…Similar effects were observed with other Tepary bean lectin fractions on different colon cancer cell lines [19,20]. In vivo studies have reported that TBLF (50 mg/kg by intragastric administration for six weeks every third day) exhibits low toxicity, good tolerability and activates the immune system [21,22]. Between the observed adverse effects are loss of body weight, small intestinal villus and colonic crypt atrophy and exocrine pancreas hypertrophy, without systemic adverse effects.…”
Section: Introductionsupporting
confidence: 71%
“…Furthermore, TBLF presents low toxicity and inhibits early tumorigenesis in rats with chemically induced colorectal cancer [19,20]. When administered intragastrically to rats, TBLF has been shown to have a stimulatory effect on the immune system and displays few side effects, such as atrophy in small intestine villus and colonic crypts and pancreatic hypertrophy, that can be partially reverted after a two-week rest period [21]. These results suggest the potential therapeutic use of Tepary bean lectins against colon cancer.…”
Section: Introductionmentioning
confidence: 79%
“…In animal models, high doses of isolated legume lectins and raw legume flours have been shown to impair the integrity of the intestinal mucosa by inducing intestinal hyperplasia, altering villus architecture, reducing disaccharidase activity, increasing intestinal permeability and activating the immune system ( Table 1 ) [ 32 , 33 ]. This change in intestinal integrity resulted in compromised nutrient absorption (protein, lipid and vitamin B12) and reduced growth of experimental animals [ 34 , 35 , 36 , 37 ].…”
Section: Lectinsmentioning
confidence: 99%